Ameriprise Financial Inc Cel Sci Corp Transaction History

Ameriprise Financial Inc

$356 Billion
Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Cel Sci Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 16,181 shares of CVM stock, worth $40,776. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,181

Previous 15,520 4.26%

Holding current value

$40,776

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.23 - $0.45 $152 - $297	661 Added 4.26%	16,181 $3,000
Q4 2024 Feb 14, 2025	SELL	$0.4 - $1.11 $100 - $277	-250 Reduced 1.59%	15,520 $6,000
Q3 2024 Nov 14, 2024	BUY	$1.05 - $1.5 $262 - $375	250 Added 1.61%	15,770 $16,000
Q2 2023 Aug 14, 2023	SELL	$2.11 - $2.83 $1,320 - $1,771	-626 Reduced 3.88%	15,520 $37,000
Q1 2023 May 15, 2023	BUY	$2.17 - $3.13 $273 - $394	126 Added 0.79%	16,146 $37,000
Q4 2022 Feb 14, 2023	SELL	$1.99 - $3.52 $2,766 - $4,892	-1,390 Reduced 7.98%	16,020 $37,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $5.23 $2,459 - $4,163	-796 Reduced 4.37%	17,410 $54,000
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $6,215 - $12,020	-2,409 Reduced 11.69%	18,206 $82,000
Q1 2022 May 16, 2022	BUY	$3.93 - $7.7 $19,335 - $37,884	4,920 Added 31.35%	20,615 $81,000
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $15,478 - $27,947	-2,180 Reduced 12.2%	15,695 $111,000
Q3 2021 Nov 15, 2021	BUY	$7.64 - $12.49 $5,424 - $8,867	710 Added 4.14%	17,875 $197,000
Q2 2021 Aug 16, 2021	BUY	$8.68 - $27.49 $10,199 - $32,300	1,175 Added 7.35%	17,165 $149,000
Q1 2021 May 17, 2021	SELL	$12.0 - $27.64 $147,120 - $338,866	-12,260 Reduced 43.4%	15,990 $243,000
Q4 2020 Feb 12, 2021	SELL	$11.05 - $16.62 $63,924 - $96,146	-5,785 Reduced 17.0%	28,250 $329,000
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $17,184 - $21,373	1,470 Added 4.51%	34,035 $434,000
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $29,542 - $53,328	3,030 Added 10.26%	32,565 $486,000
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $136,587 - $308,860	18,115 Added 158.63%	29,535 $341,000
Q1 2019 May 15, 2019	SELL	$2.58 - $3.54 $2,580 - $3,540	-1,000 Reduced 8.05%	11,420 $40,000
Q3 2018 Nov 14, 2018	BUY	$0.83 - $4.16 $10,308 - $51,667	12,420 New	12,420 $50,000

Others Institutions Holding CVM

# of Institutions

Shares Held

7.55M

Call Options Held

73.8K

Put Options Held

106K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $109M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Cel Sci Corp Transaction History